329 related articles for article (PubMed ID: 32020871)
1. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
[TBL] [Abstract][Full Text] [Related]
2. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.
Li L; Wang K; Liu Z; Lü Y; Wang C; Yi X; Guo J
World J Surg Oncol; 2022 May; 20(1):161. PubMed ID: 35590327
[TBL] [Abstract][Full Text] [Related]
3. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
He R; Ou S; Chen S; Ding S
Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
[TBL] [Abstract][Full Text] [Related]
4. An Advanced Systems Pharmacology Strategy Reveals
Zhou W; Wu C; Zhao C; Huang Z; Lu S; Fan X; Tan Y; Stalin A; You R; Liu X; Zhang J; Wu Z; Wu J
Front Cell Dev Biol; 2021; 9():742421. PubMed ID: 34646828
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology.
Zhou W; Wu J; Zhang J; Liu X; Guo S; Jia S; Zhang X; Zhu Y; Wang M
Sci Rep; 2020 Jul; 10(1):12745. PubMed ID: 32728182
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
[TBL] [Abstract][Full Text] [Related]
7. A Bioinformatics Research on Novel Mechanism of Compound Kushen Injection for Treating Breast Cancer by Network Pharmacology and Molecular Docking Verification.
Liu S; Hu X; Fan X; Jin R; Yang W; Geng Y; Wu J
Evid Based Complement Alternat Med; 2020; 2020():2758640. PubMed ID: 32849897
[TBL] [Abstract][Full Text] [Related]
8. Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology.
Huang Y; Lin J; Yi W; Liu Q; Cao L; Yan Y; Fu A; Huang T; Lyu Y; Huang Q; Wang J
Drug Des Devel Ther; 2020; 14():5109-5118. PubMed ID: 33262572
[TBL] [Abstract][Full Text] [Related]
9. Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking.
Yadav RP; Sadhukhan S; Saha ML; Ghosh S; Das M
Sci Rep; 2022 Nov; 12(1):18413. PubMed ID: 36319798
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
[TBL] [Abstract][Full Text] [Related]
11. Network Pharmacological Study of Compound Kushen Injection in Esophageal Cancer.
Guo D; Jin J; Liu J; Ren M; He Y
Curr Comput Aided Drug Des; 2023; 19(5):367-381. PubMed ID: 36635923
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology and experimental verification based research into the effect and mechanism of Aucklandiae Radix-Amomi Fructus against gastric cancer.
Song S; Zhou J; Li Y; Liu J; Li J; Shu P
Sci Rep; 2022 Jun; 12(1):9401. PubMed ID: 35672352
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Potential Mechanism of Action of Ursolic Acid against Gastric Cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
[TBL] [Abstract][Full Text] [Related]
14. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
Gao J; Yang S; Xie G; Pan J; Zhu F
Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
[TBL] [Abstract][Full Text] [Related]
15. A Network Pharmacology Analysis of the Active Components of the Traditional Chinese Medicine Zuojinwan in Patients with Gastric Cancer.
Zhang Z; Li B; Huang J; Huang S; He D; Peng W; Zhang S
Med Sci Monit; 2020 Aug; 26():e923327. PubMed ID: 32866138
[TBL] [Abstract][Full Text] [Related]
16. Study on the mechanism of ErtongKe granules in the treatment of cough using network pharmacology and molecular docking technology.
Chen YL; Li WX; Zhang H; Wang XY; Zhang SQ; Zhang ML; Han J; Li K; Feng KR; Chen XF; Tang JF
Ann Palliat Med; 2021 Nov; 10(11):11415-11429. PubMed ID: 34872267
[TBL] [Abstract][Full Text] [Related]
17. [Identification of potential targets and synergistic mechanism of Kushen Decoction for the treatment of cryptosporidiosis].
Zhan N; Liu XH; Tang FY; Zhang JY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Oct; 33(5):483-495. PubMed ID: 34791846
[TBL] [Abstract][Full Text] [Related]
18. Bioactive compounds and mechanism of Xianglian pill in the treatment of gastric cancer: Network pharmacology analysis and experimental validation.
Yu L; Sun L; Yu Q; Xiong F; Wang D; Pu L; Peng F; Xie X; Peng C
J Ethnopharmacol; 2023 Oct; 314():116573. PubMed ID: 37142148
[TBL] [Abstract][Full Text] [Related]
19. The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation.
Ming J; Liu W; Wu H; Li Y; Yang E; Wang Z; Xiao H; Quan R; Hu X
Biomed Pharmacother; 2021 Aug; 140():111767. PubMed ID: 34058439
[TBL] [Abstract][Full Text] [Related]
20. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
